Delivery Order SPE2DB20D3103-SPE2DB23FP5X4

Award Date 8/31/23
Potential Completion Date 9/22/23
Potential Value $8.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Herceptin 150 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $8,835.30 and a performance period through April 24, 2024. Amerisourcebergen Drug...
This federal contract award, valued at $20,473.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567529401 HERCEPTIN 150 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is for the delivery of 4,564,306,693 units of the drug Herceptin 150 mg vials, with a ceiling value of $21,204.72 and a completion date of May 8, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,650.59 firm fixed-price delivery order is for the supply of 150 mg vials of the drug Herceptin. The contract has an ultimate completion date of November 5, 2024 and was awarded on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Herceptin 150 mg vials. The contract is a firm fixed-price arrangement with a ceiling value of $3,534.12 and a period of performance through August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical pharmaceutical products to support various defense and federal healthcare programs. This award appears to be under a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEFT4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $21,363.36 firm fixed-price delivery order is for the supply of HERCEPTIN 150 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
This federal contract award, valued at $5,301.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,912,337 units of the pharmaceutical product Herceptin (150 mg vials) with a completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $7,951.77 for the delivery of 150 mg Herceptin vials. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP5X4
    Delivery Order

This federal contract award is for the delivery of Herceptin Hylecta 600mg-10,000 5ml to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,223.27 and a completion date of September 22, 2023. This is a delivery order contract with a firm fixed price pricing type.

The contract is not designated with any set-aside requirements, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs.

Generated 2/27/25, 11:39 AM